Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis

Abstract Malignant forms of breast cancer refractory to existing therapies remain a major unmet health issue, primarily due to metastatic spread. A better understanding of the mechanisms at play will provide better insights for alternative treatments to prevent breast cancer cell dispersion. Here, w...

Full description

Bibliographic Details
Main Authors: Alexandre G. Casanova, Gael S. Roth, Simone Hausmann, Xiaoyin Lu, Ludivine J. M. Bischoff, Emilie M. Froeliger, Lucid Belmudes, Ekaterina Bourova-Flin, Natasha M. Flores, Ana Morales Benitez, Tourkian Chasan, Marcello Caporicci, Jessica Vayr, Sandrine Blanchet, Francesco Ielasi, Sophie Rousseaux, Pierre Hainaut, Or Gozani, Muriel Le Romancer, Yohann Couté, Andres Palencia, Pawel K. Mazur, Nicolas Reynoird
Format: Article
Language:English
Published: Nature Publishing Group 2024-01-01
Series:Cell Discovery
Online Access:https://doi.org/10.1038/s41421-023-00644-x

Internet

https://doi.org/10.1038/s41421-023-00644-x

Similar Items